BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32705677)

  • 1. Critical analysis of lymph node examination in patients undergoing curative-intent resection for adrenocortical carcinoma.
    Deschner BW; Stiles ZE; DeLozier OM; Drake JA; Tsao M; Glazer ES; Deneve JL; Yakoub D; Dickson PV
    J Surg Oncol; 2020 Nov; 122(6):1152-1162. PubMed ID: 32705677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Nodal Dissection on Staging in Adrenocortical Carcinoma.
    Panjwani S; Moore MD; Gray KD; Finnerty BM; Beninato T; Brunaud L; Fahey TJ; Zarnegar R
    Ann Surg Oncol; 2017 Nov; 24(12):3617-3623. PubMed ID: 28895102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Lymphadenectomy Improve Survival in Patients with Adrenocortical Carcinoma? A Population-Based Study.
    Nilubol N; Patel D; Kebebew E
    World J Surg; 2016 Mar; 40(3):697-705. PubMed ID: 26510563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit?
    Gerry JM; Tran TB; Postlewait LM; Maithel SK; Prescott JD; Wang TS; Glenn JA; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Hatzaras I; Shenoy R; Pawlik TM; Norton JA; Poultsides GA
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):708-713. PubMed ID: 27590329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocortical Carcinoma: The Value of Lymphadenectomy.
    Tseng J; DiPeri T; Chen Y; Shouhed D; Ben-Shlomo A; Burch M; Phillips E; Jain M
    Ann Surg Oncol; 2022 Mar; 29(3):1965-1970. PubMed ID: 34792698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma Database.
    Marincola Smith P; Kiernan CM; Tran TB; Postlewait LM; Maithel SK; Prescott J; Pawlik T; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay J; Shirley LA; Fields RC; Jin L; Weber S; Salem A; Sicklick J; Gad S; Yopp A; Mansour J; Duh QY; Seiser N; Votanopoulos K; Levine EA; Poultsides G; Solórzano CC
    Ann Surg Oncol; 2018 Aug; 25(8):2308-2315. PubMed ID: 29868977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Lymph Nodes in Adrenocortical Carcinoma: What Does It Mean?
    Sada A; Glasgow AE; Lyden ML; Thompson GB; Dy BM; McKenzie TJ; Habermann EB
    World J Surg; 2021 Jan; 45(1):188-194. PubMed ID: 33034710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment.
    Reibetanz J; Rinn B; Kunz AS; Flemming S; Ronchi CL; Kroiss M; Deutschbein T; Pulzer A; Hahner S; Kocot A; Germer CT; Fassnacht M; Jurowich C
    Ann Surg Oncol; 2019 Feb; 26(2):531-538. PubMed ID: 30443830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Prognostic Value of Lymph Node Dissection in Treating Adrenocortical Carcinoma: A National Experience.
    Alanee S; Dynda D; Holland B
    Anticancer Res; 2015 Oct; 35(10):5575-9. PubMed ID: 26408728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.
    Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M;
    Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informing therapeutic lymphadenectomy: Location of regional metastatic lymph nodes in adrenocortical carcinoma.
    Sada A; Glasgow AE; Lyden ML; Dy BM; Foster TR; Habermann EB; Bancos I; McKenzie TJ
    Am J Surg; 2022 Jun; 223(6):1042-1045. PubMed ID: 34696848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence.
    Amini N; Margonis GA; Kim Y; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    Ann Surg Oncol; 2016 Jan; 23(1):126-33. PubMed ID: 26282907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes.
    Margonis GA; Kim Y; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    Ann Surg Oncol; 2016 Jan; 23(1):134-41. PubMed ID: 26286195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
    In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
    Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors.
    Bilimoria KY; Shen WT; Elaraj D; Bentrem DJ; Winchester DJ; Kebebew E; Sturgeon C
    Cancer; 2008 Dec; 113(11):3130-6. PubMed ID: 18973179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
    J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol.
    Rodriguez-Galindo C; Krailo MD; Pinto EM; Pashankar F; Weldon CB; Huang L; Caran EM; Hicks J; McCarville MB; Malkin D; Wasserman JD; de Oliveira Filho AG; LaQuaglia MP; Ward DA; Zambetti G; Mastellaro MJ; Pappo AS; Ribeiro RC
    J Clin Oncol; 2021 Aug; 39(22):2463-2473. PubMed ID: 33822640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors.
    Zaidi MY; Lopez-Aguiar AG; Dillhoff M; Beal E; Poultsides G; Makris E; Rocha F; Crown A; Idrees K; Marincola Smith P; Nathan H; Beems M; Abbott D; Barrett JR; Fields RC; Davidson J; Cardona K; Maithel SK
    JAMA Surg; 2019 Feb; 154(2):134-140. PubMed ID: 30383112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma.
    Werntz RP; Riedinger CB; Fantus RJ; Smith ZL; Packiam VT; Adamsky MA; Smith N; Steinberg GD
    Urol Oncol; 2018 Dec; 36(12):526.e1-526.e6. PubMed ID: 30446445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group.
    Poorman CE; Ethun CG; Postlewait LM; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solórzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
    Ann Surg Oncol; 2018 Feb; 25(2):520-527. PubMed ID: 29164414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.